What Clinicians Have To Find Out Before Designing A Chlamydia Treatment Plan

Getting answers to some questions would facilitate the development of a treatment plan for the condition known as Chlamydia. The answers to these questions may prove to be the very things that would make the whole process of designing a treatment plan easier for them. More importantly, it is on the basis of the answers given to these questions that a clinician can be in a position to develop a treatment plan that doesn't harm the patient. You have to remember that it is possible to harm a patient in the course of treatment (especially if, as a clinician, you don't have adequate information). 
There were cases where expectant women have suffered through miscarriages because they have been prescribed the wrong medication. Some are also put at risk when it turns out that the medications used in the treatment plan are actually triggers to allergic reactions in the patient. There is great need to be careful since these possibilities are always looming over clinicians' heads. Generally, treatment plans for Chlamydia rely heavily on medications that are antibiotic in nature. Thus, developing a treatment plan in this case is all about figuring out the specific medications to prescribe. But before you could figure out which medications to use, you should have some questions answered first.
Pregnancy among female patients is something the clinician should look into before he could start developing a Chlamydia treatment plan. Clarithromycin and ofloxacin are often prescribed to Chlamydia patients, but these are not for pregnant women. That means the clinician would probably make do with other medications that would be safe for pregnant women, and that includes amoxicillin. Erithromycin has also been proven safe for use by pregnant women. Make it a point to ask them straight out if they are pregnant or not. Most pregnant women these days do not show too much, so they might think they are not pregnant when, in fact, they are. Again, we have seen some rather unexpected people getting pregnant (including older women). Thus, you should make it a point to make that inquiry about the state of their pregnancy before you start doing preparations for the treatment of their Chlamydia condition.
It is also important for the clinician to probe into whether or not the patient has certain reactions to specific medications. This will serve as a guide for the clinician when they plan out which medications to use in the treatment for Chlamydia. But the hard part would be trying to figure out which are allergic reactions and which are actually side effects of the drugs administered to the patient.
The patient may have a regular sexual partner. This is another thing the Chlamydia patient should try to find out before he can start putting together a treatment plan. If the answer is yes, the partner should also be included in the plan and be prescribed certain medications. Otherwise you'd be setting the ground for immediate re-infection which may, in due course, give rise to drug resistance.